University of Colorado Cancer Center

 

University of Colorado Cancer Center
T

NKT Cell Development and Activation: Implications in Cancer Immunotherapy

By University of Colorado Cancer Center FEATURING Tonya Webb
By University of Colorado Cancer Center FEATURING Tonya Webb
2 views
March 17, 2022
0 Comments
Login to view comments. Click here to Login
Oncology Grand Rounds
46:54
University of Colorado Cancer Center

Targeting Transcriptional Addiction in High-Risk Pediatric Cancers W…

Feat. A. Durbin
48:02
University of Colorado Cancer Center

Computational Modeling of the Tumor Ecosystem

Feat. S. Finley
47:26
University of Colorado Cancer Center

Discovery of Targets for Bipotent Anticancer Drug

Feat. A. Sahu
46:48
University of Colorado Cancer Center

Theranostics and the Changing Face of Prostate Cancer

Feat. M. Morris
36:02
University of Colorado Cancer Center

Multicancer Early Detection Assays: Are They Ready for Prime Time?

Feat. M. Wood
53:57
University of Colorado Cancer Center

What Will It Take to Cure Cancer? Historical Context and Future Dire…

Feat. C. Lieu
45:51
University of Colorado Cancer Center

Adventures in Keratinocyte Carcinoma Chemoprevention

Feat. M. Weinstock
41:41
University of Colorado Cancer Center

Increasing Epitope Spreading to Improve CAR-T Therapy for Solid Tumo…

Feat. M. Leibowitz
55:46
University of Colorado Cancer Center

UColorado Updates on Hepatocellular Carcinoma and Biliary Tract Canc…

Feat. L. Davis
50:41
University of Colorado Cancer Center

NKT Cell Development and Activation: Implications in Cancer Immunoth…

Feat. T. Webb
39:22
University of Colorado Cancer Center

Prevention of Obesity-Associated Colorectal Cancer: Mechanistic Appr…

Feat. C. V. Rao
30:24
University of Colorado Cancer Center

MRD in MM: How We Measure Disease Generally and What It Means for th…

Feat. B. Harry
40:19
University of Colorado Cancer Center

Practical Principles of Biomarker Testing in Advanced Non-Small Cell…

Feat. T. Patil
40:38
University of Colorado Cancer Center

CAR T-Cell and BiTE Therapy for mCRPC: Trials and Tribulations

Feat. T. Barauskas Dorff
37:39
University of Colorado Cancer Center

How Molecular Analysis for Endometrial Cancer Effects Treatment

Feat. B. Corr
60:49
University of Colorado Cancer Center

Advanced Stage Melanoma in 2021: Disease Overview & Management o…

Feat. T. Medina
41:18
University of Colorado Cancer Center

2021 Advances in Bladder Cancer and Immunotherapy

Feat. T. Flaig
43:13
University of Colorado Cancer Center

Translational Immunotherapy in Sarcomas: Distinct Immune Subsets and…

Feat. B. Wilky
16:30
University of Colorado Cancer Center

2021 Updates on Gynecologic Oncology: Impact on Patients, Overview o…

Feat. B. Bitler, S. Guntupalli, C. Walsh
15:20
University of Colorado Cancer Center

CAR T-Cells & Cancer Immunotherapy: Overview of Different Approa…

Feat. C. Smith, E. Davila, M. Kamdar, B. Wilky
56:18
University of Colorado Cancer Center

Best Practices in Flow and Mass Cytometry-Based Research: From Exper…

Feat. E. Clambey
10:02
University of Colorado Cancer Center

Updates in Neuro-Oncology & New Technologies: Impact on Patients…

Feat. D. Damek, K. Lillehei, W. Messersmith
06:41
University of Colorado Cancer Center

Updates in Neuro-Oncology: The Use of 3D Imaging

Feat. D. Damek, K. Lillehei, W. Messersmith
07:51
University of Colorado Cancer Center

Updates in dMMR/MSI CRC: Overview of Recent Immunotherapy Advances

Feat. W. Messersmith
16:17
University of Colorado Cancer Center

Timely Diagnosis of Pediatric Brain Tumors: General Approach to Visi…

Feat. A. Green
13:38
University of Colorado Cancer Center

Colorado University Updates on Lung Cancer Research: The Future for …

Feat. R. Camidge, J. Degregori
17:45
University of Colorado Cancer Center

Early-Onset Colorectal Cancer Case: Expert Discussion

Feat. C. Bradley, J. Vogel, C. Lieu
14:36
University of Colorado Cancer Center

Expert Discussion on Pancreatic Cancer Research: Impact on Patients …

Feat. M. Del Chiaro, S. Karam, C. Meguid
10:18
University of Colorado Cancer Center

Colorado University Highlights on Prostate Cancer Research: Unmet Ne…

Feat. T. Flaig, E. Kessler, S. Kim, P. Maroni
09:31
University of Colorado Cancer Center

Colorado University Updates on Breast Cancer Research: Impact on Pat…

Feat. J. Diamond, V. Borges
14:57
University of Colorado Cancer Center

Colorado University Highlights on BC Research: Inhibiting Tumor Cell…

Feat. H. Ford, J. Richer, T. Lyons
37:29
University of Colorado Cancer Center

Liquid Biopsies for Pediatric Sarcomas: Can We Use Them in Targeting…

Feat. M. Hayashi
18:14
University of Colorado Cancer Center

Overview of HR+/HER2+ BC: Prevalence in the US, Subtypes, and Design…

Feat. E. Shagisultanova
10:59
University of Colorado Cancer Center

Triplet Targeting Combination in HR+/HER2+ BC: Understanding Signali…

Feat. E. Shagisultanova
10:50
University of Colorado Cancer Center

Surveying Efficacy Data of Tucatinib, Palbociclib and Letrozole Comb…

Feat. E. Shagisultanova
36:50
University of Colorado Cancer Center

Targeting Advanced Prostate Cancer With a Focus on RB-Deficient Tumo…

Feat. K. Knudsen
52:08
University of Colorado Cancer Center

Intrapatient Subpopulation Heterogeneity and the Potential Ramificat…

Feat. D. Sherbenou
11:03
University of Colorado Cancer Center

Updates on TNBC: Risk Factors, Hereditary Syndromes, Screening for M…

Feat. J. Diamond
07:12
University of Colorado Cancer Center

TNBC Highlights: 3D Mammography, MRI, Chemoprevention, Basic Biology

Feat. J. Diamond
34:36
University of Colorado Cancer Center

Management of Early Stage and Metastatic TNBC: Principles of Neoadju…

Feat. J. Diamond
10:43
University of Colorado Cancer Center

MET Signaling in NSCLC: Importance of Biomarker Development & Ba…

Feat. T. Patil
08:13
University of Colorado Cancer Center

Diagnostic Challenges of MET Signaling in NSCLC: Polysomy vs. Amplif…

Feat. T. Patil
10:37
University of Colorado Cancer Center

Brain Mets & CNS Coverage of MET Signaling in NSCLC: Alectinib v…

Feat. T. Patil
09:36
University of Colorado Cancer Center

Future Directions in MET Signaling in NSCLC: Developing Novel Biomar…

Feat. T. Patil
38:12
University of Colorado Cancer Center

CTNNB1 Mutation in Endometrial Cancer: Rationale for Wnt Inhibition …

Feat. B. Corr
16:12
University of Colorado Cancer Center

Venetoclax in Acute Myeloid Leukemia: Targeting BCL-2, Drug Developm…

Feat. D. Pollyea
29:56
University of Colorado Cancer Center

Venetoclax Combinations in AML: Addition of Aza/Dec in Previously Un…

Feat. D. Pollyea